Russia has offered to share its skills and technical know-how with Malaysia to help the country become a vaccine producer and reduce dependency on other countries, its ambassador to Malaysia Naiyl M. Latypov told Malay Mail. Russia may be on the cusp of a geopolitical shake-up that could put the nation on par with other major technological powers thanks to its Sputnik V vaccine. Kremlin officials said up to 50 countries are already on the verge or have approved the use of Sputnik V on their population, having received over two billion orders for the vaccine by the end of February. Russian Ambassador Latypov said his country has offered to collaborate in capacity building, technology sharing and research and development of vaccines with Malaysia. Isn’t it better to be able to produce your own vaccines?” he quipped during an interview earlier this week. Do you think (Covid-19) will be the only pandemic? We are willing to share our skills and knowledge so when the next pandemic comes, Malaysia can already make its own vaccine,” added the ambassador. Malaysia can have vaccine independence.” To date, Russia is the only country that has made such an offer to Malaysia. Latypov said Malaysia’s location makes it geographically strategic as a regional base to export the vaccines. All countries in the region, except Singapore, have shown an interest in the Sputnik V, according to news reports. I understand that it takes just two or three hours to travel anywhere (in South-east Asia) from Malaysia. That is why we feel Malaysia is a good place to have this because exporting vaccines will be easy,” he told Malay Mail. Sputnik V’s developer, the state-backed Gamaleya National Research Institute of Epidemiology and Microbiology, will work directly in collaboration with local players, which Latypov said will help foster trust and speed up progress. The Russian Investment Development Fund, the vaccine’s sole marketing agent for global supply, will oversee exports.
(Feb 4): Solution Group Bhd said on Thursday that it has signed a term sheet agreement with the government to supply 3.5 million doses of Covid-19 vaccine jointly developed by China's CanSino Biologics Inc and Beijing Institute of Biotechnology under the Academy of Military Medical Sciences. Solution Group to supply 3.5 mil doses of CanSino vaccine to govt . Under the agreement, Solution will deliver the vaccine from its subsidiary's storage facility to a government appointed central store or logistics partner. Prime Minister Muhyiddin Yassin said earlier on Thursday that Malaysia expects to complete its Covid-19 immunisation programme by February next year, covering 80% of its population of about 32 million people.